Skip to main content

Table 2 Audit of clinical records

From: Clinical audit of multidisciplinary care at a medium-sized hospital in Spain

Relevant cancer conference Cases MDT discussion Prospective presentation Written documentation Explicitly documented cTNM Explicitly documented pTNM Diagnostic delay Therapeutic delay
General 496 320 (64.5%) 198 (40%) 259 (52%) 118 (23.8%) 266 (53.6%) 33 21
Gastrointestinal 147 124 (84.3%) 87 (59.1%) 116 (78.9%) 58 (39.4%) 89 (60.5%) 30 21
Breast 46 43 (93%) 38 (82.6%) 43 (93%) 9 (19.5%) 35 (76%) 28 28
Lung 68 36 (52.9%) 15 (21.7%) 10 (14.5%) 11 (16.1%) 24 (35.3%) 13 10
Hematology 33 14 (42%) 7 (21%) 8 (24%) na na na na
Urology 81 46 (56.7%) 15 (18.5%) 28 (34.5%) 11 (13.5%) 52 (64.2%) 46 33
Gynecology 23 19 (82.6%) 10 (43.5%) 16 (69.6%) 5 (21.7%) 16 (69.6%) 34 31
H and N 28 16 (57%) 8 (28.6%) 8 (28.6%) 11 (39.3%) 19 (67.8%) 46 19
Sarcomas 5 5 (100%) 2 (40%) 1 (20%) 1 (20%) 3 (60%) 41 15
Melanoma 16 14 (87.5%) 2 (40%) 11 (68.7%) 3 (18.7%) 11 (68.7%) 13 56
Other: Unknown origin, Thyroid, Brain, Peritoneum 41 4 (9.7%) 2 (4.9%) 1 (2.4%) 1 (2.4%) 7 (17.1%) 50 23
  1. H and N, head and neck; na, not available due to the specific characteristics of hematological cancers. MDT (multidisciplinary team); cTNM (clinical staging); pTNM (pathological staging).